Literature DB >> 1618596

IL-6 receptor and mechanism of signal transduction.

T Kishimoto1, S Akira, T Taga.   

Abstract

Interleukin-6 (IL-6) is a multifunctional cytokine which acts on a wide variety of cells, exerting growth promotion, growth inhibition, or specific gene expression including cellular differentiation. The IL-6 receptor system consists of two membrane proteins, a ligand-binding chain (IL-6R) and a non-ligand-binding signal transducer, gp130, both of which belong to the cytokine receptor family. Binding of IL-6 to IL-6R triggers the association of IL-6R and gp130, and gp130 in turn transduces the signal. Despite its lack of IL-6 binding property, gp130 is involved in the formation of high-affinity IL-6 binding sites. This two-chain IL-6 receptor system can be applied to some other cytokine receptors, such as IL-3R, IL-5R and GM-CSFR which share a second signal-transducing component. A nuclear factor for controlling IL-6 gene expression (NF-IL6) is a leucine zipper-containing transcription factor and is homologous to C/EBP, a liver nuclear factor. NF-IL6 is also involved in the transcriptional regulation of various acute phase protein genes IL-6-triggered association of IL-6R and gp130 on hepatocytes, through intermediate steps including serine-phosphorylation of pre-existing NF-IL6 protein, leads to binding of NF-IL6 to IL-6-responsive elements and activation of acute-phase protein genes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1618596     DOI: 10.1016/0192-0561(92)90173-i

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  18 in total

1.  Interleukin-6 trans-signaling in the senescent mouse brain is involved in infection-related deficits in contextual fear conditioning.

Authors:  Michael D Burton; Rodney W Johnson
Journal:  Brain Behav Immun       Date:  2011-10-29       Impact factor: 7.217

Review 2.  Cord blood--an alternative source for bone regeneration.

Authors:  Marcus Jäger; Christoph Zilkens; Bernd Bittersohl; Rüdiger Krauspe
Journal:  Stem Cell Rev Rep       Date:  2009-08-04       Impact factor: 5.739

Review 3.  Multiple myeloma: increasing evidence for a multistep transformation process.

Authors:  M Hallek; P L Bergsagel; K C Anderson
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

Review 4.  IL-6-like cytokines and cancer cachexia: consequences of chronic inflammation.

Authors:  B E Barton
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

5.  C/EBPbeta is a negative regulator of human papillomavirus type 11 in keratinocytes.

Authors:  H Wang; K Liu; F Yuan; L Berdichevsky; L B Taichman; K Auborn
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

6.  The immune response modifier imiquimod requires STAT-1 for induction of interferon, interferon-stimulated genes, and interleukin-6.

Authors:  R L Bottrel; Y L Yang; D E Levy; M Tomai; L F Reis
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

7.  Expression of the IL-6 receptor alpha-chain (CD126) in normal and abnormal plasma cells in monoclonal gammopathy of undetermined significance and smoldering myeloma.

Authors:  Dalia Abdel-Raouf Salem; Neha Korde; David J Venzon; David J Liewehr; Irina Maric; Katherine R Calvo; Raul Braylan; Prashant R Tembhare; Constance M Yuan; Carl Ola Landgren; Maryalice Stetler-Stevenson
Journal:  Leuk Lymphoma       Date:  2017-05-25

8.  Lipopolysaccharide up-regulates IL-6R alpha expression in cultured leptomeningeal cells via activation of ERK1/2 pathway.

Authors:  Ting Wang; Bai-Ren Wang; Hua-Zhou Zhao; Fang Kuang; Juan Fan; Xiao-Li Duan; Gong Ju
Journal:  Neurochem Res       Date:  2008-03-21       Impact factor: 3.996

9.  Interleukin-6 mediates the platelet abnormalities and thrombogenesis associated with experimental colitis.

Authors:  Elena Y Senchenkova; Shunsuke Komoto; Janice Russell; Lidiana D Almeida-Paula; Li-Sue Yan; Songlin Zhang; D Neil Granger
Journal:  Am J Pathol       Date:  2013-05-11       Impact factor: 4.307

10.  Central inhibition of interleukin-6 trans-signaling during peripheral infection reduced neuroinflammation and sickness in aged mice.

Authors:  Michael D Burton; Jennifer L Rytych; Gregory G Freund; Rodney W Johnson
Journal:  Brain Behav Immun       Date:  2013-01-23       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.